An AI model using mammogram images predicts 5-year breast cancer risk more accurately than traditional breast density assessment.
Key Details
- 1The study is presented at the RSNA annual meeting in Chicago.
- 2Clairity Breast, the first FDA-authorized image-only AI breast cancer risk model, was trained on over 421,000 mammograms.
- 3AI model performance was evaluated on more than 245,000 screening mammograms from the US and Europe.
- 4Women in the AI high-risk group had a >4x higher incidence of cancer (5.9%) than average-risk (1.3%), while density-based separation was modest (3.2% vs. 2.7%).
- 5Findings support integrating image-only AI risk scores with traditional risk factors for more personalized screening strategies.
Why It Matters
This research advances precision screening in breast imaging, offering radiologists a more nuanced, data-driven tool for risk stratification. Early identification of high-risk patients via AI could lead to tailored screening protocols and improved outcomes.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.